[1,2-a]
[1,2-b]
[1,2-c]
[1,2-d]
[1,2-f]
[1,2-x]
[1,5-a]
[1,5-b]
[1,5-c]
[1,5-d]
[1,6-ad][1,7-a]
[2,1-a]
[2,1-b]
[2,1-c]
[2,1-d]
[2,1-e]
[2,1-f]
[2,1-]
[2,3-a]
[2,3-b]
[2,3-c]
[2,3-d]
[2,3-e]
[2,3-f]
[2,3-g]
[2,3-h]
[2,3-ij][2,4-b]
[3,2-a]
[3,2-b]
[3,2-c]
[3,2-d]
[3,2-e]
[3,2-g]
[3,2-f]
[3,2-h]
[3,4-a]
[3,4-b]
[3,4-c]
[3,4-d]
[3,4-e]
[3,4-f]
[3,4-g]
[3,4-]
[4,3-a]
[4,3-b]
[4,3-c]
[4,3-d]
[4,3-e]
[4,3-g]
[4,3-]
[4,5-a]
[4,5-b]
[4,5-c]
[4,5-d]
[4,5-e]
[4,5-f]
[4,5-g]
[4,5-h]
[4,5-]
[5,1-a]
[5,1-b]
[5,1-c]
[5,1-f]
[5,1-]
[5,4-b]
[5,4-c]
[5,4-d]
[5,4-e]
[5,4-f]
[5,4-]
[5,6-b]
[5,6-c]
[5,6-]
[6,1-b]
[6,1-]
[6,5-b]
[6,5-]
Order
156145-74-3
Bicyclo[3.1.0]hexan-3-one, 2-(1-hydroxyethylidene)-6,6-dimethyl-, (1S,5R)-
Order
1561-47-3
1-Butanol, 2,4,4,4-tetrachloro-, acetate
Order
156151-21-2
2-Naphthalenecarbonitrile,4-(3-furanyl)-7-[[5-(tetrahydro-4-hydroxy-2H-pyran-4-yl)-3-pyridinyl]methoxy]-
Order
1561-52-0
2-IODOTETRAFLUOROETHYL TRIFLUOROMETHYL ETHER
Order
156152-21-5
6-Hydroxy-1-phenylnaphthalene
Order
15615-39-1
boron 10-methylphenoxathiin-10-ium fluoride (1:1:4)
Order
156153-98-9
9H-Xanthen-9-one,1,2,3,4-tetrahydro-1,3,6-trihydroxy-1-[(6-hydroxy-4-oxo-4H-pyran-2-yl)methyl]-8-methyl-,(1S-trans)-
Order
156154-35-7
3H-Imidazo[4,5-b]pyridine, 2-ethyl-3,5,7-trimethyl-
Order
156154-37-9
Losartan-hydrochlorothiazide mixture
Order
156154-38-0
1,4-Benzodioxin, piperazine deriv.
Order
156154-42-6
3-Cyclohexene-1-carboxylic acid,4-[(4-chlorophenyl)amino]-6-methyl-2-oxo-, methyl ester, trans-
Order
15615-50-6
dichloroplatinum(2+)ato(5-) biphenyl-2,2'-diylbisazanido(5-)
Order
156158-90-6
1H-3a,6-Methanoazulen-7(4H)-one,hexahydro-4-hydroxy-3,6,8,8-tetramethyl-, [3S-(3a,3ab,4a,6b,8ab)]-
Order
156162-10-6
4H-1-Benzopyran-4-one,2-[2,4-dihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]-2,3-dihydro-5-hydroxy-7-methoxy-8-(3-methyl-2-buten-1-yl)-,(2S)-
Order
156162-14-0
Gammapyrone
Order
156162-44-6
INACTIVATION GATE PEPTIDE